Stock Events

Stock Events

StemRIM 

$2.08
5
+$0.00+0% Tuesday 12:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
130.37M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9SepExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.06
-0.05
-0.05
-0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-12.6MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
TAK
Mkt Cap57.58B
Takeda Pharmaceutical Company Limited is a major competitor in the biotechnology and pharmaceutical sectors, directly competing with StemRIM in the development of regenerative medicine and therapies.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. competes in the pharmaceutical and biotechnology industries, focusing on innovative therapies that may overlap with StemRIM's regenerative medicine projects.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. is involved in the research and development of pharmaceutical products, including regenerative medicine, making it a direct competitor to StemRIM.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. specializes in biopharmaceuticals, competing with StemRIM in the field of regenerative medicine and biotechnological research.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited operates in the pharmaceutical sector, focusing on innovative drugs that could compete with StemRIM's regenerative medicine solutions.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse portfolio of pharmaceutical products, including those in the realm of regenerative medicine, positioning it as a competitor to StemRIM.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. is known for its research and development in the pharmaceutical field, including areas that overlap with StemRIM's focus on regenerative medicine.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. focuses on pharmaceuticals and biotechnologies, including regenerative medicine, making it a competitor in the same niche as StemRIM.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Tsumura & Co. is involved in the healthcare and pharmaceutical industry, with a focus on traditional and innovative medicines that could compete with StemRIM's offerings.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. operates in the pharmaceutical sector, developing products that could rival StemRIM's regenerative medicine and biotechnology solutions.

About

StemRIM is a biotechnology firm dedicated to developing regenerative medicines aimed at treating severe and challenging diseases. Its product pipeline includes PJ1, a regeneration-inducing medicine based on HMGB1 peptides, which is currently undergoing Phase II clinical trials for a range of conditions such as epidermolysis bullosa, cerebral infarction, osteoarthritis, chronic liver disease, and cardiomyopathy. Beyond PJ1, StemRIM is also advancing PJ2, another regeneration-inducing medicine utilizing novel peptides A and B; PJ3, a biologic protein designed to promote regeneration; PJ4, a device for collecting a patient's own cells for therapeutic purposes; and PJ5, a stem cell-based gene therapy. Established in 2006, StemRIM is headquartered in Ibaraki, Japan.
Show more...
CEO
Employees
45
Country
Japan
ISIN
JP3399690001

Listings

OTC Link
US
SRIMF
TSE
JP
4599.TSE

0 Comments

Share your thoughts

FAQ

What is StemRIM stock price today?▼
The current price of SRIMF is $2.08 USD — it has increased by +0% in the past 24 hours. Watch StemRIM stock price performance more closely on the chart.
What is StemRIM stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange StemRIM stocks are traded under the ticker SRIMF.
Is StemRIM stock price growing?▼
SRIMF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year StemRIM has showed a +0% increase.
What is StemRIM market cap?▼
Today StemRIM has the market capitalization of 130.37M
When is the next StemRIM earnings date?▼
StemRIM is going to release the next earnings report on September 09, 2026.
What were StemRIM earnings last quarter?▼
SRIMF earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is StemRIM revenue for the last year?▼
StemRIM revenue for the last year amounts to 0 USD.
What is StemRIM net income for the last year?▼
SRIMF net income for the last year is -12.6M USD.
How many employees does StemRIM have?▼
As of September 04, 2026, the company has 45 employees.
In which sector is StemRIM located?▼
StemRIM operates in the Other sector.
When did StemRIM complete a stock split?▼
StemRIM has not had any recent stock splits.